4//SEC Filing
Sabba Stephen L 4
Accession 0000899243-22-039408
CIK 0000886163other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 6:30 PM ET
Size
9.3 KB
Accession
0000899243-22-039408
Insider Transaction Report
Form 4
Sabba Stephen L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-12-22+6,623→ 6,623 totalExercise: $67.03Exp: 2032-12-22→ Common Stock (6,623 underlying)
Footnotes (1)
- [F1]Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001442372
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 6:30 PM ET
- Size
- 9.3 KB